J&J Begins Human Testing of Ebola-Virus Vaccine

06 Jan 2015

“Johnson & Johnson on Tuesday said it has begun testing its Ebola-virus vaccine in humans and will have more than 400,000 doses available in April.”

Source: J&J Begins Human Testing of Ebola-Virus Vaccine – WSJ

OODA Analyst

OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.

J&J Begins Human Testing of Ebola-Virus Vaccine

OODA Analyst

Dog disease that can be passed to humans confirmed in Iowa

North Korea warns of food crisis, slashes rations before next leaders’ summit

Startup Tech CEO: How can you learn government mission needs?

Cyber Threat Analysis Report Vol 1, Edition 7

North Korea says nuclear talks at risk if US-South Korea exercises go ahead

Privacy Experts: Facebook’s $5B Fine Unlikely to Do Much

Failures in Cybersecurity Fundamentals Still Primary Cause of Compromise: Report

Nearly 20% of Organizations Still Run Windows 7

Infographic: Why email is your weakest security link

Instagram Account Takeover Vulnerability Earns Hacker $30,000

Evite Invites Over 100 Million People to Their Data Breach

Meet DoppelPaymer, BitPaymer’s Ransomware Lookalike

J&J Begins Human Testing of Ebola-Virus Vaccine

OODA Analyst

You Might Also Like

Dog disease that can be passed to humans confirmed in Iowa

North Korea warns of food crisis, slashes rations before next leaders’ summit

J&J Begins Human Testing of Ebola-Virus Vaccine